標題: Titlebook: Cancer Immunotherapy at the Crossroads; How Tumors Evade Imm James H. Finke,Ronald M. Bukowski Book 2004 Springer Science+Business Media Ne [打印本頁] 作者: 兇惡的老婦 時間: 2025-3-21 16:19
書目名稱Cancer Immunotherapy at the Crossroads影響因子(影響力)
書目名稱Cancer Immunotherapy at the Crossroads影響因子(影響力)學(xué)科排名
書目名稱Cancer Immunotherapy at the Crossroads網(wǎng)絡(luò)公開度
書目名稱Cancer Immunotherapy at the Crossroads網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Cancer Immunotherapy at the Crossroads被引頻次
書目名稱Cancer Immunotherapy at the Crossroads被引頻次學(xué)科排名
書目名稱Cancer Immunotherapy at the Crossroads年度引用
書目名稱Cancer Immunotherapy at the Crossroads年度引用學(xué)科排名
書目名稱Cancer Immunotherapy at the Crossroads讀者反饋
書目名稱Cancer Immunotherapy at the Crossroads讀者反饋學(xué)科排名
作者: 相反放置 時間: 2025-3-21 21:59
978-1-4684-9844-8Springer Science+Business Media New York 2004作者: motor-unit 時間: 2025-3-22 03:43 作者: Occipital-Lobe 時間: 2025-3-22 04:35
KangWoo Lee,Jung-Hoon Hwang,Dong-Soo Kwontibility complex (MHC) molecules. However, the TCR : MHC interaction is insufficient to trigger productive activation of T cells. It is now widely recognized that a second signal known as costimulation is required for the productive activation of antigen (Ag)-specific T cells.作者: 血友病 時間: 2025-3-22 10:16
Accentuating Tumor Immunity Through Costimulationtibility complex (MHC) molecules. However, the TCR : MHC interaction is insufficient to trigger productive activation of T cells. It is now widely recognized that a second signal known as costimulation is required for the productive activation of antigen (Ag)-specific T cells.作者: 神圣不可 時間: 2025-3-22 15:17 作者: 神圣不可 時間: 2025-3-22 17:26
Current Clinical Oncologyhttp://image.papertrans.cn/c/image/221140.jpg作者: 一致性 時間: 2025-3-22 23:00 作者: Interstellar 時間: 2025-3-23 04:56
Aineas Mallios,Ted Lindblom,Stefan Sj?grennate the malignant cells and the chronic infectious agent. This setting is not uncommon in mice or patients with a congenital or acquired immunodeficiencies. However, this problem is also frequently seen in fully immunocompetent individuals, suggesting that malignant cells and certain microorganisms作者: Daily-Value 時間: 2025-3-23 07:31
Kristaps Freimanis,Maija ?enfelded proliferation of different immune cells. Na?ve T cells are unable to directly recognize tumor antigens. They require help from specialized cells known as professional antigen-presenting cells (APCs). APCs first interact with tumors, uptake tumor cells/proteins, process them, and present antigenic 作者: CHAFE 時間: 2025-3-23 13:04
Aineas Mallios,Ted Lindblom,Stefan Sj?gren responses .. In their purest form, such strategies take the form of adoptively transferred, enriched populations of tumor-reactive CD8+ T cells. These approaches have occasionally been shown to be capable of mediating the regression of lesions in cancer patients .. However, more often, high circula作者: padding 時間: 2025-3-23 14:58 作者: stress-test 時間: 2025-3-23 19:56
Kristaps Freimanis,Maija ?enfeldends on the surface of multiple types of tumor cells has led to the recognition that tumor cells may escape destruction by immune effector cells, and may be actively involved in the killing of Fas-expressing lymphocytes. Thus, the Fas/Fas ligand (Fas/FasL) interaction serves both as a mechanism of cy作者: preeclampsia 時間: 2025-3-24 02:00 作者: rectocele 時間: 2025-3-24 06:17 作者: Esalate 時間: 2025-3-24 09:20
Pravin Chandrasekaran,R. Muthucumaraswamyntigen-presenting cells (APC) such as dendritic cells (DC), and a supportive cytokine milieu. Cytokines present at the immunization site—or in the case of tumors, the tumor site—have been shown to have a marked effect on the magnitude as well as the nature of the response. They play a role in recrui作者: 智力高 時間: 2025-3-24 12:32 作者: 勤勉 時間: 2025-3-24 17:55
Pravin Chandrasekaran,R. Muthucumaraswamyria-laden large intestine .–.. Such chronic tolerance is as important to the immune system as its capacity to destroy pathogens, since it is essential that the host does not reject a growing fetus or loops of bowel that house commensual bacteria. A vast array of physiological immunosuppressive facto作者: cipher 時間: 2025-3-24 22:15
New Challenges in Banking and Financeions in the apoptotic pathways may determine tumor resistance to current therapeutic strategies. An understanding of the molecular mechanisms involved in the regulation of apoptosis and how tumor cells evade apoptotic death may provide insight into the processes of carcinogenesis and the progression作者: 歹徒 時間: 2025-3-24 23:19
Communication Issues in Integrative Oncology insufficient to induce cancer rejection or—although adequate for this task—are most often counteracted by an evolving disease that is capable of escaping them through continuous phenotypic changes. A combination of the two is probably at the basis of the relatively rare observation of tumor regress作者: arousal 時間: 2025-3-25 06:30
https://doi.org/10.1007/978-1-4614-3369-9f immune surveillance advanced the notion that the immune system protected the host from insults by infectious agents and played a significant role in elimination of abnormal cells. On the other hand, evidence indicating that cancer developed and progressed in subjects with a normally functioning im作者: neurologist 時間: 2025-3-25 08:15 作者: Classify 時間: 2025-3-25 14:03 作者: 離開就切除 時間: 2025-3-25 16:46 作者: 最小 時間: 2025-3-25 23:14
HLA Class I Antigen-Processing Machinery and HLA Class I Antigen-Derived Peptide-Complex Defects in assays in patients with active specific immunotherapy have poor, if any, predictive value . and that lack of clinical response and/or recurrence of disease occur frequently, despite induction and/or persistence of TAAspecific immune responses .. Considering the genetic instability of tumor cells ., 作者: VICT 時間: 2025-3-26 02:20 作者: 吹氣 時間: 2025-3-26 07:26 作者: Mindfulness 時間: 2025-3-26 11:18 作者: TOXIN 時間: 2025-3-26 14:36 作者: 樂章 時間: 2025-3-26 17:46
Allogeneic Hematopoietic Blood-Cell Transplantation As Immunotherapy for Metastatic Renal Cell Carcivestigators have begun to pursue an alternative immune-based strategy in patients who fail to respond to conventional cytokines—namely, immune enhancement via total immune replacement following “l(fā)ow-intensity” nonmyeloablative allogeneic stem-cell transplantation (NST). NST has recently been shown t作者: Ingrained 時間: 2025-3-26 22:44
Immune Defects in Patients Suffering From Non-Hodgkin’s Lymphomaarious cellular players of the immune system. An understanding of this interaction will lead to the third part of this chapter, in which we describe efforts made to manipulate the immune system in order to mount a clinically relevant antitumor immune response.作者: Amplify 時間: 2025-3-27 02:59
2364-1134 ed with the capacity to monitor the strength and quality of patients‘ immune responses using immunocytometry, MHC-peptide tetramers combined with apoptosis assay, ELISPOT assay, and detection of MHC-TAA peptide complexes on tumor cells.978-1-4684-9844-8978-1-59259-743-7Series ISSN 2364-1134 Series E-ISSN 2364-1142 作者: extinct 時間: 2025-3-27 08:19
Nutrition, Education, Sanitation,assays in patients with active specific immunotherapy have poor, if any, predictive value . and that lack of clinical response and/or recurrence of disease occur frequently, despite induction and/or persistence of TAAspecific immune responses .. Considering the genetic instability of tumor cells ., 作者: Fecundity 時間: 2025-3-27 13:22 作者: 忙碌 時間: 2025-3-27 13:42
Kristaps Freimanis,Maija ?enfeldesignificantly unbalanced in the presence of the tumor. A variety of different processes involved in the immune response have been impaired in the tumor-bearing hosts. For example, multiple tumor-produced factors exhibit immunomodulatory properties, and play an important role in the regulation of tum作者: 善于 時間: 2025-3-27 19:01 作者: 樹上結(jié)蜜糖 時間: 2025-3-28 00:33 作者: 顧客 時間: 2025-3-28 02:32 作者: 展覽 時間: 2025-3-28 06:35 作者: 進入 時間: 2025-3-28 13:08
New Challenges for the Banking Industrye biology. Experimental data indicates that many tumor antigens are ignored by tumor-specific T cells in tumor-bearing animals and in cancer patients. In this chapter, we summarize the current status of research and the methods that may be utilized to overcome T-cell ignorance with the goal of achieving more effective antitumor T-cell responses.作者: 關(guān)節(jié)炎 時間: 2025-3-28 17:03
Nuno Baetas da Silva,António Portugal Duartemmatory responses involving the expression of IFN-γ and IL-2 mRNA,. In a subset of patients, diminished T-cell function has also been observed in the peripheral blood, which is mostly associated with reduced production of TH1 type cytokines (e.g., IFN-γ) following stimulation of peripheral-blood T cells with mitogens or anti-CD3 antibody ..作者: aqueduct 時間: 2025-3-28 21:14
Ewa Madalińska-Bugaj,Linh Anh Nguyenhe syngeneic normal host, and form progressively growing tumors. It is highly likely—and increasingly recognized—that local tumor cell—host interactions influence the initial steps of tumor formation.作者: 矛盾 時間: 2025-3-29 01:49
Pravin Chandrasekaran,R. Muthucumaraswamyrs, including interleukin (IL)-10, transforming growth factor-β (TGF-β), and cyclic adenosine 5′ monophosphate (cAMP)-elevating prostaglandins, contribute to the induction and maintenance of such tolerance, and are variously produced by T lymphocytes themselves and/or by ambient host cells such as macrophages .–..作者: 鎮(zhèn)壓 時間: 2025-3-29 03:26
Book 2004rder to more effectively support the process of tumor rejection in situ. Cutting-edge techniques are outlined with the capacity to monitor the strength and quality of patients‘ immune responses using immunocytometry, MHC-peptide tetramers combined with apoptosis assay, ELISPOT assay, and detection of MHC-TAA peptide complexes on tumor cells.作者: Esophagitis 時間: 2025-3-29 08:01 作者: etiquette 時間: 2025-3-29 12:35
Altered Signaling in T Lymphocytes of Patients With Cancert transfer of T lymphocytes, antibodies, or cytokines to tumor-bearing hosts was often successful in the control of tumor growth in animals .,., but frequently failed in man .. By then, the field of tumor immunology had evolved, and principles of tumor immunity had been established.作者: deciduous 時間: 2025-3-29 17:54 作者: 肉體 時間: 2025-3-29 23:31
Communication Issues in Integrative Oncologysuccess of most anticancer immunization strategies. We also discuss strategies that may help to understand this complex phenomenon, with the ultimate goal of identifying the true algorithm that modulates the immune rejection of cancer.作者: overreach 時間: 2025-3-30 03:43
CD4+ T-Cell-Mediated Immunity to Cancerogic response modifiers, such as interleukin-2 (IL-2) .. Although it is not the purpose of this chapter to survey all of the potential mechanisms that may underlie the ineffectiveness of such immune effector cells ., one must consider deviation in the functional antitumor CD4+ T “helper” compartment as a major confounding variable.作者: patriarch 時間: 2025-3-30 07:29
The Development and Reversal of T-Cell Tolerance in Cancer Patients Receiving Peptide-Based Vaccinessuccess of most anticancer immunization strategies. We also discuss strategies that may help to understand this complex phenomenon, with the ultimate goal of identifying the true algorithm that modulates the immune rejection of cancer.作者: Tinea-Capitis 時間: 2025-3-30 08:56
2364-1134 e immune system and then spell out possible clinical strategies to prevent or reverse tumor-induced immune dysfunction. The authors review the mechanisms of immune dysfunction and evasion mechanisms in histologically diverse human tumors, focusing on tumor-induced molecular defects in T cells and an作者: Digest 時間: 2025-3-30 13:38
New Challenges in Banking and Finance in the regulation of apoptosis and how tumor cells evade apoptotic death may provide insight into the processes of carcinogenesis and the progression of various malignancies, making it possible to use more rational approaches to antitumor therapy.作者: 注入 時間: 2025-3-30 17:17
Janusz Sobecki,Dmitrij ?atuchincomposition: a minority of neoplastic cells in an abundant inflammatory background. This background consists of varying amounts of T and B lymphocytes, plasma cells, eosinophilic granulocytes, and histiocytes, and usually comprises more than 99% of the tumor mass.作者: Circumscribe 時間: 2025-3-30 22:50
Tumor Resistance to Apoptosis in the regulation of apoptosis and how tumor cells evade apoptotic death may provide insight into the processes of carcinogenesis and the progression of various malignancies, making it possible to use more rational approaches to antitumor therapy.作者: HEED 時間: 2025-3-31 04:20
Immune Dysfunction in Classical Hodgkin’s Lymphomacomposition: a minority of neoplastic cells in an abundant inflammatory background. This background consists of varying amounts of T and B lymphocytes, plasma cells, eosinophilic granulocytes, and histiocytes, and usually comprises more than 99% of the tumor mass.作者: 偽書 時間: 2025-3-31 05:01 作者: 揮舞 時間: 2025-3-31 10:37 作者: 轉(zhuǎn)換 時間: 2025-3-31 16:44 作者: consolidate 時間: 2025-3-31 19:17
The Role of Tumor Gangliosides in the Immune Dysfunction of Cancerhe syngeneic normal host, and form progressively growing tumors. It is highly likely—and increasingly recognized—that local tumor cell—host interactions influence the initial steps of tumor formation.作者: 稀釋前 時間: 2025-4-1 00:15 作者: 錢財 時間: 2025-4-1 05:28 作者: 橫截,橫斷 時間: 2025-4-1 07:51
Immune Defects in T Cells From Cancer Patientsnate the malignant cells and the chronic infectious agent. This setting is not uncommon in mice or patients with a congenital or acquired immunodeficiencies. However, this problem is also frequently seen in fully immunocompetent individuals, suggesting that malignant cells and certain microorganisms作者: JADED 時間: 2025-4-1 13:59 作者: folliculitis 時間: 2025-4-1 17:00 作者: CLOT 時間: 2025-4-1 20:22 作者: 使服水土 時間: 2025-4-1 23:57
